WA
ABBV icon

WestEnd Advisors’s AbbVie ABBV Stock Holding History

WestEnd Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$40K Buy
159
+21
+15% +$4.52K ﹤0.01% 63
2026
Q1 		$30K Hold
138
– – ﹤0.01% 62
2025
Q4 		$31.5K Buy
138
+85
+160% +$19.4K ﹤0.01% 61
2025
Q3 		$12.3K Sell
53
-24
-31% -$4.89K ﹤0.01% 74
2025
Q2 		$14.3K Buy
77
+8
+12% +$1.49K ﹤0.01% 73
2025
Q1 		$14.5K Buy
69
+19
+38% +$3.69K ﹤0.01% 69
2024
Q4 		$8.88K Sell
50
-2
-4% -$368 ﹤0.01% 74
2024
Q3 		$10.2K Sell
52
-2
-4% -$373 ﹤0.01% 67
2024
Q2 		$9.18K Sell
54
-7
-11% -$1.16K ﹤0.01% 66
2024
Q1 		$11K Sell
61
-452
-88% -$77.9K ﹤0.01% 63
2023
Q4 		$79.4K Sell
513
-127,663
-100% -$18.6M ﹤0.01% 51
2023
Q3 		$19.1M Buy
128,176
+29,506
+30% +$4.33M 0.57% 34
2023
Q2 		$13.3M Buy
+98,670
New +$14.5M 0.39% 37
2023
Q1 		– Sell
-113,179
Closed -$17.3M – 35
2022
Q4 		$18.3M Buy
113,179
+2,338
+2% +$358K 0.6% 36
2022
Q3 		$14.9M Sell
110,841
-11,043
-9% -$1.58M 0.5% 36
2022
Q2 		$18.7M Buy
+121,884
New +$18.6M 0.59% 34
2022
Q1 		– Sell
-13
Closed -$1.89K – 75
2021
Q4 		$1.76K Buy
+13
New +$1.54K ﹤0.01% 83
2021
Q3 		– Hold
0
– – – 87
2021
Q2 		– Hold
0
– – – 76

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

WestEnd Advisors's ABBV Position: Q2 2026 in Review

WestEnd Advisors increased its AbbVie (ABBV) stake by 15% in Q2 2026, buying an estimated $4.52K and bringing the position to 159 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #63.

WestEnd Advisors first reported a position in ABBV in Q4 2021 and has held it in 17 quarters since. The position peaked at $19.1M in Q3 2023. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • WestEnd Advisors held 159 shares of AbbVie worth $40K as of Q2 2026.
  • WestEnd Advisors bought 21 AbbVie shares in Q2 2026, an estimated $4.52K.
  • AbbVie made up ﹤0.01% of WestEnd Advisors's portfolio in Q2 2026, its #63 holding.
  • WestEnd Advisors first reported a position in AbbVie in Q4 2021 and has held it in 17 quarters since.
  • WestEnd Advisors's AbbVie position peaked at $19.1M in Q3 2023.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on WestEnd Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.